849.90
+13.70
+(1.64%)
At close: April 17 at 4:04:25 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 31 | 30 | 47 | 45 |
| Avg. Estimate | 10.97B | 11.23B | 44.34B | 49.65B |
| Low Estimate | 10.77B | 11.04B | 43.59B | 47.92B |
| High Estimate | 11.22B | 11.59B | 45.86B | 53.11B |
| Year Ago Sales | 9.56B | 9.82B | 39B | 44.34B |
| Sales Growth (year/est) | 14.73% | 14.27% | 13.70% | 11.96% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NFCD.XC | -- | -- | -- | -- |
| S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 4/17/2025 |
| Maintains | UBS: Buy to Buy | 4/15/2025 |
| Reiterates | Wedbush: Outperform to Outperform | 4/11/2025 |
| Maintains | Keybanc: Overweight to Overweight | 4/9/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 4/8/2025 |
| Reiterates | Guggenheim: Buy to Buy | 4/3/2025 |